表紙
市場調查報告書

慢性病管理:治療、設備技術、全球市場

Chronic Disease Management: Therapeutics, Device Technologies and Global Markets

出版商 BCC Research 商品編碼 917143
出版日期 內容資訊 英文 376 Pages
訂單完成後即時交付
價格
Back to Top
慢性病管理:治療、設備技術、全球市場 Chronic Disease Management: Therapeutics, Device Technologies and Global Markets
出版日期: 2019年11月15日內容資訊: 英文 376 Pages
簡介

預估全球慢性病管理的治療和設備技術市場規模將從2019年的3,460億美元,以7.2%的CAGR (複合年均成長率) 成長,於2024年擴大至4,900億美元規模。

本報告提供過共晶合金技術進步與市場機會相關情報,彙整材料類型、技術、應用、按地區的過共晶合金新興市場分析、市場趨勢分析、CAGR (複合年均成長率) 預測、主要機會和課題等情報。

第1章 前言

第2章 摘要與重點

第3章 慢性病和增加的經濟負擔

  • 慢性病背景
  • 流行病學和全球負擔
  • 慢性病類型
  • 抽菸和慢性病
  • 老化、性別和慢性病
  • 目前課題和未來方向

第4章 慢性病:治療

  • 治療和慢性病
  • 治療的臨床需求
  • 治療和成本負擔
  • 慢性病和管理照護
  • 主要上市和PIPELINE藥物
  • 未滿足需求
  • 目前課題和未來發展

第5章 設備技術和應用

  • 醫療設備和慢性病管理
  • 數位治療的臨床與市場需求
  • 設備技術類型
  • 主要上市和R&D/PIPELINE藥物
  • 透過數位照護的慢性病管理優勢
  • 未滿足需求
  • 醫療保健和安全監控的未來發展
  • 目前課題
  • 未來展望

第6章 慢性病:治療依順設備和應用

  • 治療不依順
  • 服藥依順性系統和應用的市場需求
  • 服藥依順性系統和應用的類型
  • 主要上市和PIPELINE藥物
  • 軟體和行動應用優勢
  • 目前課題
  • 未來展望

第7章 市場規模和成長分析

  • 市場規模和成長分析
  • 市場成長推動和阻礙因素

第8章 慢性病管理市場競爭情勢

  • 競爭情勢:透過新治療和尖端設備技術進行慢性病管理

第9章 慢性病管理市場策略

  • 慢性病管理市場的整合
  • 慢性病管理市場的併購
  • 近年併購
  • 未來策略情勢

第10章 監管結構:藥物和醫療設備

  • 監管背景
  • 醫療設備監管系統:按地區
  • 藥物監管系統:按地區

第11章 價格和醫療費用償付:藥物和醫療設備

  • 價格和醫療費用償還背景
  • 醫療設備價格和醫療費用償還:按地區
  • 藥物價格和醫療費用償還:按地區

第12章 結論:慢性病管理展望

  • 影響市場的主要發展
  • 慢性病管理長期展望

第13章 企業簡介

第14章 附錄A:縮略語列表

第15章 附錄B:專門機構

目錄
Product Code: HLC239A

Report Highlights:

The global market for chronic disease management therapeutics and device technologies should grow from $346 billion in 2019 to $490 billion by 2024, at a compound annual growth rate (CAGR) of 7.2% from 2019 through 2024.

The U.S. market for chronic disease management therapeutics and device technologies should grow from $169 billion in 2019 to $248 billion by 2024, at a CAGR of 8.0% from 2019 through 2024.

The Asia-Pacific market for chronic disease management therapeutics and device technologies should grow from $42 billion in 2019 to $65 billion by 2024, at a CAGR of 9.1% from 2019 through 2024.

Report Scope:

Chronic disease management includes various drug and medical device-based techniques used for the management of various chronic diseases. This report is an analytical business tool with the primary purpose of providing a thorough evaluation of the global market for chronic disease management through various therapeutics and advanced device technologies. The format of this study includes the following -

  • Detailed description, including demographics and cost burden, of various chronic diseases including cancer, diabetes, cardiovascular disorders, respiratory diseases, musculoskeletal disorders, neurological disorders, GI diseases, immune disorders, mental disorders and others (ostomy, urology disorders, chronic wounds etc.).
  • Detailed description and analysis of current therapeutics (drugs, biologics) and device technologies (traditional medical devices, drug-device combinations, wearable and other monitoring devices).
  • Market characterization, unmet need, market size and segmentation (by region, by segment, by diseases, by drug delivery, by treatment adherence, by health settings).
  • Market drivers and restraints.
  • Detailed market projections through 2024.
  • Competition and market shares.
  • Key marketed and pipeline (research and development) products along with information about their regulatory status.
  • Strategic landscape (mergers and acquisitions).
  • Regulatory structure.
  • Pricing and reimbursement.
  • Observations and conclusions on the future of chronic disease management.
  • Profiles of market participants and associations.

Report Includes:

  • 30 data tables and 46 additional tables
  • Brief outline of the global markets and therapeutic device technologies for chronic disease management
  • Analyses of global market trends with data from 2018, estimates for 2019, and projections of compound annual growth rates (CAGRs) through 2024
  • Key insight into the current state of chronic diseases and disorders, with an emphasis on advance needle-free drug delivery technologies, diagnostic methods, and smart device technologies that support effective disease state management
  • Data corresponding to global chronic disease management markets by disease type that includes various chronic diseases, therapeutic drugs, treatment adherence devices & systems, drug delivery technologies, and treatment & management providers
  • Regulatory structure for pharmaceuticals and medical devices, pricing and reimbursement structure, marketed and pipeline products, and major developments influencing the market
  • Detailed company profiles and competitive landscape of major market players, including Roche, AbbVie, Johnson & Johnson, Bristol-Myers Squibb, Merck and GlaxoSmithKline

Table of Contents

Chapter 1: Introduction

  • Study Goals and Objectives
  • Reasons for Doing This Study
  • Scope of Report
  • Information Sources
  • Methodology and Information Sources
  • Geographic Breakdown
  • Analyst's Credentials
  • BCC Custom Research
  • Related BCC Research Reports

Chapter 2: Summary and Highlights

Chapter 3: Chronic Diseases and Growing Burden on Economy

  • Background of Chronic Diseases
  • Epidemiology and Global Burden
  • Chronic Diseases Types
    • Cardiovascular Disease
    • Lifestyle Disorders
    • Cancer
    • Respiratory Disorders
    • Musculoskeletal Disorders
    • Mental/Mood Disorders
    • Gastro-Intestinal Disorders
    • Immune Disorders
    • Neurological Disorders
    • Other Chronic Disorders
  • Tobacco Smoking and Chronic Diseases
  • Aging, Gender and Chronic Diseases
    • Global Demographics
    • U.S. Demographics
    • U.S: Gender, Age and Life Expectancy
    • European Demographics
    • Japanese Demographics
  • Current Challenges and Future Directions

Chapter 4: Chronic Diseases: Therapeutics

  • Therapeutics and Chronic Diseases
    • Generic Drugs and Chronic Diseases
    • Generic Drugs vs. Branded Drugs
    • Continued Resistance for Generics
    • Biologics and Biosimilars for Immune-Mediated Chronic Diseases
    • Cancer and Targeted Therapy
  • Clinical Need of Therapeutics
  • Therapeutics and Cost Burden
  • Chronic Diseases and Managed Care
  • Key Marketed and Pipeline Products
    • Key Marketed Products
    • Key Pipeline/R&D Products
  • Unmet Need
  • Current Challenges and Future Developments

Chapter 5: Device Technologies and Applications

  • Medical Devices and Chronic Disease Management
  • Clinical and Market Need of Digital Therapeutics
  • Types of Device Technologies
    • Diagnostic and Monitoring Devices
    • Therapeutic Devices and Technologies
  • Key Marketed and R&D/Pipeline Products
    • Diagnostic and Monitoring Devices
    • Therapeutic Devices and Technologies
  • Advantages of Chronic Disease Management via Digital Care
  • Unmet Need
  • Future Developments for Healthcare and Safety Monitoring
  • Current Challenges
  • Future Outlook

Chapter 6: Chronic Diseases: Treatment Adherence Devices and Applications

  • Treatment Nonadherence
  • Market Need for Medication Adherence Systems and Applications
  • Types of Medication Adherence Systems and Applications
    • Hardware-Centric Medication Adherence Systems
    • Medication Adherence Software Applications
  • Key Marketed and Pipeline Products
    • Hardware-Centric Medication Adherence Systems
    • Medication Adherence Software Applications
  • Software and Mobile Application Advantages
    • Interconnectivity of Adherence App
    • Effectiveness of Smartphone Adherence Apps
  • Current Challenges
  • Future Developments

Chapter 7: Market Size and Growth Analysis

  • Market Size and Growth Analysis
    • Market Size and Growth Analysis, by Region
    • Market Size and Growth Analysis, by Product Segment
    • Market Size and Growth Analysis, by Chronic Disease Type
    • Market Size and Growth Analysis, by Treatment Provider and Target Health Settings
  • Market Growth Drivers and Restraints
    • Market Growth Drivers
    • Market Restraints

Chapter 8: Competitive Landscape in the Chronic Disease Management Market

  • Competitive Landscape: Chronic Disease Management with New Therapeutics and Advanced Device Technologies

Chapter 9: Strategies in the Chronic Disease Management Market

  • Consolidation in the Chronic Disease Management Market
  • Mergers and Acquisitions in the Chronic Disease Management Market
  • Recent Mergers and Acquisitions
    • Device Technologies
    • Therapeutics (Drugs and Biologics)
    • Minority Stakes and Future Options to Acquire
  • Future Strategic Landscape

Chapter 10: Regulatory Structure: Pharmaceuticals and Medical Devices

  • Regulatory Background
  • Regulatory Systems for Medical Devices, by Region
    • U.S.
    • European Union
    • Japan
  • Regulatory Systems for Pharmaceuticals, by Region
    • U.S.
    • Europe
    • Japan

Chapter 11: Pricing and Reimbursement: Pharmaceuticals and Medical Devices

  • Pricing and Reimbursement Background
  • Pricing and Reimbursement for Medical Devices, by Region
    • U.S.
    • Europe
    • Japan
    • Other Asia-Pacific
  • Pricing and Reimbursement for Pharmaceuticals, by Region
    • U.S.
    • Europe
    • Japan

Chapter 12: Conclusions - Outlook for Chronic Disease Management

  • Major Developments Influencing the Market
    • Technological Developments
    • Demographic and Economic Trends
    • Changing Structure of the Healthcare Industry
    • Lifestyle Medicine
    • Patient-Centric Programs
  • Long-Term Outlook for Chronic Disease Management

Chapter 13: Company Profiles

  • 3RINGS
  • ABBOTT LABORATORIES
  • ABBVIE INC.
  • ACADIA PHARMACEUTICAL
  • ACORDA THERAPEUTICS
  • ACTUALMEDS
  • AGENUS
  • ACTAVIS PLC
  • ADHERIUM
  • AKRON
  • ALIVECOR
  • AMGEN INC.
  • AMIKO
  • ANIMAS (A SUBSIDIARY OF JOHNSON & JOHNSON)
  • ANI PHARMACEUTICALS
  • ALIPHCOM
  • ALLERGAN
  • ALKERMES
  • AMNEAL PHARMACEUTICALS
  • ANAVEX LIFE SCIENCES
  • APOTEX
  • ARCHOS
  • ARENA PHARMACEUTICALS
  • ARRAY BIOPHARMA
  • ASLAN PHARMACEUTICALS
  • ASAHI KASAI CORP.
  • ASPEN PHARMACARE
  • ASTRAZANECA PLC
  • ASTELLAS PHARMA INC.
  • ATHERSYS
  • AUDENTES THERAPEUTICS
  • AXIOBIONICS
  • AXSOME THERAPEUTICS
  • AYOGO HEALTH
  • BAUSCH HEALTH
  • BAYER AG
  • BESPAK EUROPE
  • BEIGENE
  • BIOXCEL THERAPEUTICS
  • BIOSENSICS
  • BIOSERENITY
  • BIOTRONIK GMBH
  • BIOTRICITY
  • BIOVOTION
  • BODYTEL
  • BOEHRINGER INGELHEIM
  • BOSTON SCIENTIFIC
  • BRISTOL-MYERS SQUIBB
  • BRAINMARC
  • BTS BIOENGINEERING
  • CARDIOMEMS INC. (A SUBSIDIARY OF ST. JUDE)
  • CELGENE
  • CHUGAI PHARMACEUTICALS CO., LTD.
  • CIPLA
  • CLEVELAND MEDICAL DEVICE
  • CLOVIS ONCOLOGY
  • CONNECTEDHEALTH PTE. LTD.
  • CORBUS PHARMACEUTICALS
  • CSPC PHARMACEUTICAL GROUP
  • DAIICHI SANKYO
  • DEXCOM INC.
  • DEPOMED INC.
  • DR. REDDY'S LABORATORIES LTD.
  • EARLYSENSE
  • EDWARDS LIFESCIENCES CORP.
  • EISAI
  • ELI LILLY
  • EMPATICA
  • ENDO INTERNATIONAL
  • ENDOTRONIX
  • ENTRA HEALTH SYSTEMS
  • ENDOCEUTICS INC.
  • ERYTECH PHARMA
  • ESTEVE
  • EVERIST HEALTH
  • FIVE PRIME THERAPEUTICS
  • GLAXOSMITHKLINE PLC
  • GLOOKO, INC.
  • GILEAD SCIENCES
  • GLUCOVISTA INC.
  • GOODLUX TECHNOLOGY LLC
  • HALOZYME THERAPEUTICS
  • HEALTH CARE ORIGINALS
  • HIKMA PHARMACEUTICALS
  • HOCOMA
  • IHEALTH
  • IMMUNOMEDICS
  • IMPACT SPORTS TECHNOLOGIES
  • IMPAK HEALTH
  • INFOBIONIC INC.
  • INSULET CORP.
  • INTELESENS
  • INTRA-CELLULAR THERAPIES
  • IOVANCE BIOTHERAPEUTICS
  • IPSEN S.A.
  • JAN MEDICAL INC.
  • JIANGSU HENGRUI MEDICINE
  • JOHNSON & JOHNSON
  • LUNDBECK
  • LUPIN
  • KYOWA HAKKO KIRIN
  • LES LABORATOIRES SERVIER
  • LIVANOVA PLC
  • MALLINCKRODT PLC
  • MEDTRONIC
  • MEDTRONIC MINIMED INC. (A SUBSIDIARY OF MEDTRONIC)
  • MEDCONNECTIONS INC.
  • MEDMINDER
  • MENARINI
  • MERCK
  • MIO GLOBAL
  • MITSUBISHI TANABE PHARMA
  • MYLAN INC.
  • MYCARDIO LLC
  • NEMAURA MEDICAL INC.
  • NEOFECT CO., LTD.
  • NEUROCRINE BIOSCIENCES
  • NEUROMETRIX INC.
  • NEUROVIGIL INC.
  • NOVARTIS
  • NOVO NORDISK
  • NOVASOM INC.
  • NUCANA
  • OMADA HEALTH INC.
  • OMRON CORP.
  • OMNICELL INC.
  • ONO PHARMACEUTICAL CO., LTD.
  • ORION PHARMA LTD.
  • ORPYX MEDICAL TECHNOLOGIES
  • OTSUKA PHARMACEUTICALS
  • PACIRA PHARMACEUTICALS INC.
  • PFIZER
  • PHILOSYS
  • POLAR ELECTRO OY
  • PREVENTICE INC.
  • PRESCRIBEWELLNESS LLC
  • PRIZM MEDICAL INC.
  • PROPELLER HEALTH
  • PROTEUS DIGITAL HEALTH INC.
  • PROTEOSTASIS THERAPEUTICS
  • QARDIO
  • REHAB-ROBOTICS (A MEMBER OF VINCENT MEDICAL HOLDINGS)
  • REXAHN PHARMACEUTICALS
  • ROCHE
  • SAGE THERAPEUTICS
  • SANOFI
  • SAREPTA THERAPEUTICS
  • SENSE4CARE
  • SENSEONICS HOLDINGS
  • SENTICARE INC.
  • SHANGHAI PHARMACEUTICALS HOLDING
  • SHIONOGI AND CO., LTD.
  • SILVERGENS
  • SPROUTLING INC. (ACQUIRED BY MANTTEL)
  • ST. JUDE MEDICAL (A SUBSIDIARY OF ABBOTT LABORATORIES)
  • STADA ARZNEIMITTEL AG
  • SUMITOMO DAINIPPON PHARMA CO., LTD.
  • SUN PHARMACEUTICAL INDUSTRIES
  • TAKEDA PHARMACEUTICAL CO., LTD.
  • TAISHO PHARMACEUTICAL
  • TCR2 THERAPEUTICS
  • TEVA PHARMACEUTICAL INDUSTRIES
  • TOWERVIEW HEALTH, INC.
  • TRANSLATE BIO
  • TYME TECHNOLOGIES
  • UCB
  • UNILIFE CORP.
  • VERTEX PHARMACEUTICAL
  • VAICA
  • VITAL CONNECT
  • WEST PHARMACEUTICAL SERVICES INC.
  • WINMEDICAL SRL
  • YBRAIN
  • YPSOMED HOLDING AG
  • ZOGENIX INC.
  • ZYDUS CADILA

Chapter 14: Appendix A: List of Acronyms

Chapter 15: Appendix B: Professional Organizations

  • American Heart Association
  • Center for Drug Evaluation and Research (CDER)
  • Center for Devices and Radiological Health (CDRH)
  • Centers for Medicare and Medicaid Services (CMS)
  • European Databank for Medical Devices (EUDAMED)
  • Food and Drug Administration (FDA or USFDA)
  • Hormone Foundation
  • International Diabetes Federation (IDF)
  • International Federation of Pharmaceutical Manufacturers and Associations (IFPMA)
  • Network for Excellence in Health Innovation (NEHI)
  • National Center for Biotechnology Information (NCBI)
  • National Institute of Aging (NIA)
  • Pharmaceuticals and Medical Devices Agency (PMDA)
  • World Cancer Research Fund International
  • World Health Organization (WHO)

List of Tables

  • Summary Table: Overall Global Market for Chronic Disease Management Therapeutics and Device Technologies, by Region, Through 2024
    • Table 1: Global Deaths Share, by Various Chronic Disease Types, 2018
    • Table 2: Global DALYs Share, by Various Chronic Disease Types, 2018
    • Table 3: Global Incidence Share of Hypertension, by Patient Group Type, 2018
    • Table 4: Global Prevalence of Angina Pectoris and Stroke (Survivors), Through 2030
    • Table 5: Global Prevalence of Congestive Heart Failure and Stroke, Through 2030
    • Table 6: Structural Heart Disease, Management Through Medication
    • Table 7: BMI Calculation
    • Table 8: BMI Categories Based on Increasing Health Risks
    • Table 9: Trends in Obesity Composition of the World's Population, Through 2025
    • Table 10: U.S. Obesity and Severe Obesity vs. General Population, Through 2025
    • Table 11: Global Diabetes Types Share
    • Table 12: Global Prevalence of Diabetes, by Type, Through 2040
    • Table 13: Global Prevalence of Breast Cancer, by Country/Region, Through 2025
    • Table 14: Global Epidemiology of Colorectal Cancer, by Region, Through 2030
    • Table 15: Global Deaths, by Various Cancer Types, Through 2030
    • Table 16: Global Deaths Share, by Various Cancer Types, 2015
    • Table 17: Global Symptomatic Prevalence of Key Musculoskeletal Disorders, Through 2025
    • Table 18: Global Deaths, by Various Musculoskeletal Disorders, Through 2030
    • Table 19: Global Deaths from Digestive Diseases, by Region, Through 2025
    • Table 20: Estimated World Population and Annual Growth, by Selected Age Group, Through 2030
    • Table 21: World Population, by Selected Region, Through 2030
    • Table 22: U.S. Population Estimates and Projections, by Age Group, Through 2030
    • Table 23: Estimates of Anticipated U.S. Life Expectancy at Birth, by Gender, Through 2020
    • Table 24: European Population Estimates and Projections, by Age Group, Through 2030
    • Table 25: Japanese Population Estimates and Projections, by Age Group, Through 2030
    • Table 26: Key Marketed Products, Respiratory Disorders - Therapeutics
    • Table 27: Key Marketed Products, Mood Disorders - Therapeutics
    • Table 28: Key Marketed Products, Musculoskeletal Disorders - Therapeutics
    • Table 29: Key Marketed Products, Neurovascular Disorders - Therapeutics
    • Table 30: Key Marketed Products, Immune Disorders - Therapeutics
    • Table 31: Key Marketed Products, Diabetes - Therapeutics
    • Table 32: Key Marketed Products, Cardiovascular Disorders - Therapeutics
    • Table 33: Key Marketed Products, GI Disorders - Therapeutics
    • Table 34: Key Marketed Products, Cancer - Therapeutics
    • Table 35: Key Pipeline/R&D Products, Cancer - Therapeutics
    • Table 36: Key Pipeline/R&D Products, Neurological Disorders - Therapeutics
    • Table 37: Key Pipeline/R&D Products, Cardiovascular Disorders - Therapeutics
    • Table 38: Key Pipeline/R&D Products, GI Disorders - Therapeutics
    • Table 39: Key Pipeline/R&D Products, Musculoskeletal Disorders - Therapeutics
    • Table 40: Key Pipeline/R&D Products, Diabetes - Therapeutics
    • Table 41: Key Pipeline/R&D Products, Mood Disorders - Therapeutics
    • Table 42: Key Marketed and Pipeline/R&D Devices, Cardiac Monitoring Devices and Technologies
    • Table 43: Key Marketed and Pipeline/R&D Devices, Continuous Glucose monitoring Devices and Technologies
    • Table 44: Key Marketed and Pipeline/R&D Devices, Sleep-Monitoring Devices
    • Table 45: Key Marketed and Pipeline/R&D Devices, Vital Sign and Activity Monitoring Devices and Technologies
    • Table 46: Key Marketed and Pipeline/R&D Devices, Pain Management Devices and Technologies
    • Table 47: Key Marketed and Pipeline/R&D Devices, Drug delivery Devices and Technologies
    • Table 48: Smart Pills for Patient Monitoring
    • Table 49: Smart Pills for Oral Drug Delivery
    • Table 50: Key Marketed and Pipeline/R&D Devices, Insulin delivery Devices and Technologies
    • Table 51: Global Medication Adherence Percentages, by Chronic Diseases
    • Table 52: Automated Medication Dispensing Cabinets
    • Table 53: Smart Pill Dispensers, Pillboxes and Organizers
    • Table 54: Medication Tracking Devices and Apps
    • Table 55: Pill Organizer and Reminder Systems
    • Table 56: Smart Pill Cap and Bottle Systems
    • Table 57: Other Medication Adherence Solutions
    • Table 58: Health and Medication Reminder Apps
    • Table 59: Personalized Medication Adherence and Text Messaging Apps
    • Table 60: Health and Medication Monitoring Apps
    • Table 61: Cloud-Based Adherence Solutions and Databases
    • Table 62: Health and Medication Adherence Apps
    • Table 63: Other Medication adherence Apps
    • Table 64: Global Market for Chronic Disease Management Therapeutics and Device Technologies, by Region, Through 2024
    • Table 65: Global Market for Chronic Disease Management Therapeutics and Device Technologies, by Product Segment, Through 2024
    • Table 66: Global Market for Treatment Adherence Systems and Applications for Chronic Disease Management, by Segment, Through 2024
    • Table 67: Global Market for Chronic Disease Management Therapeutics and Device Technologies, by Disease Type, Through 2024
    • Table 68: Global Market for Chronic Disease Management Therapeutics, by Leading Company, 2018
    • Table 69: Global Market for Chronic Disease Management Device Technologies, by Leading Company, 2018
    • Table 70: Key Strategic Deals in the Chronic Disease Management and Device Technology Market, 2012-2019
    • Table 71: Key Strategic Deals in Chronic Disease Management Therapeutics Market, 2016-2019
    • Table 72: Key Strategic Deals for Business Units, Minority Stakes and Future Options to Acquire in the Chronic Disease Management Market, 2016-2019
    • Table 73: Differences in Regulatory Approval in the U.S. and Europe
    • Table 74: Trends in Per Capita Real Gross Domestic Product Growth, by Region, 2015-2018
    • Table 75: List of Acronyms Used in Chronic Disease Management

List of Figures

  • Summary Figure: Overall Global Market for Chronic Disease Management Therapeutics and Device Technologies, by Region, 2018-2024
    • Figure 1: Global Deaths Share, by Various Chronic Disease Types, 2018
    • Figure 2: Global DALYs Share, by Various Chronic Disease Types, 2018
    • Figure 3: Global Incidence Share of Hypertension, by Patient Group Type, 2018
    • Figure 4: Global Prevalence of Angina Pectoris and Stroke (Survivors), 2004-2030
    • Figure 5: Global Prevalence of Congestive Heart Failure and Stroke, 2004-2030
    • Figure 6: Trends in Obesity Composition of the World's Population, 2012-2025
    • Figure 7: U.S. Obesity and Severe Obesity vs. General Population, 2018-2025
    • Figure 8: Global Diabetes Types Share
    • Figure 9: Global Prevalence of Diabetes, by Type, 2018-2040
    • Figure 10: Global Prevalence of Breast Cancer, by Country/Region, 2018-2025
    • Figure 11: Global Epidemiology of Colorectal Cancer, by Region, 2000-2030
    • Figure 12: Global Deaths, by Various Cancer Types, 2000-2030
    • Figure 13: Global Deaths Share, by Various Cancer Types, 2015
    • Figure 14: Global Symptomatic Prevalence of Key Musculoskeletal Disorders, by Region, 2018
    • Figure 15: Global Deaths Share, by Various Musculoskeletal Disorders, 2015
    • Figure 16: Global Deaths from Digestive Diseases, by Region, 2018-2025
    • Figure 17: Estimated World Population and Annual Growth, by Selected Age Group, 2000-2030
    • Figure 18: World Population, by Selected Region, 2000-2030
    • Figure 19: U.S. Population Estimates and Projections, by Age Group, 2000-2030
    • Figure 20: Estimates of Anticipated U.S. Life Expectancy at Birth, by Gender, 2005-2020
    • Figure 21: European Population Estimates and Projections, by Age Group, 2000-2030
    • Figure 22: Japanese Population Estimates and Projections, by Age Group, 2000-2030
    • Figure 23: Global Market for Chronic Disease Management Therapeutics and Device Technologies, by Region, 2018-2024
    • Figure 24: Global Market for Chronic Disease Management Therapeutics and Device Technologies, by Product Segment, 2018-2024
    • Figure 25: Global Market Share for Therapeutics, by Drug Type, 2018
    • Figure 26: Global Market Share for Therapeutics, by Delivery Technology, 2017
    • Figure 27: Global Market Share for Device Technologies, by Device Type, 2017
    • Figure 28: Global Market for Treatment Adherence Systems and Applications for Chronic Disease Management, by Segment, 2018-2024
    • Figure 29: Global Market for Chronic Disease Management Therapeutics and Device Technologies, by Disease Type, 2018-2024
    • Figure 30: Global Market Share for Therapeutics and Device Technologies, by Treatment Provider and Target Health Settings, 2017
    • Figure 31: Global Market Share for Chronic Disease Management Therapeutics, by Leading Company, 2018
    • Figure 32: Global Market Share for Chronic Disease Management Device Technologies, by Leading Company, 2018
    • Figure 33: Trends in Per Capita Real Gross Domestic Product Growth, by Region, 2015-2018
Back to Top